Omega Fund Management, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Omega Fund Management, Llc disclosed 9 stock positions valued at approximately $185.69M as of quarter-end June 30, 2026. The largest holdings include Bicara Therapeutics Inc., Nuvation Bio Inc., and BridgeBio Oncology Therapeutics Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 9
- Portfolio Value
- $185.69M
Holdings by Sector
Omega Fund Management, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | BCAX | Healthcare | 29.14% | 1,822,150 | -570,000 | -23.83% | $54,099,634 |
| Nuvation Bio Inc. | NUVB | Healthcare | 24.72% | 8,081,089 | - | - | $45,900,586 |
| BridgeBio Oncology Therapeutics Inc. | BBOT | Healthcare | 13.50% | 3,289,661 | - | - | $25,067,217 |
| Beta Bionics Inc. | BBNX | Healthcare | 11.11% | 1,316,183 | - | - | $20,624,588 |
| Alumis Inc. | ALMS | Healthcare | 3.66% | 241,255 | - | - | $6,788,916 |
| Sana Biotechnology, Inc. | SANA | Healthcare | 1.59% | 843,750 | - | - | $2,944,688 |
| ImageneBio, Inc. | IMA | Healthcare | 1.45% | 455,361 | - | - | $2,686,630 |
| enGene Holdings Inc. | ENGN | Healthcare | 0.82% | 876,357 | - | - | $1,516,098 |
| Odyssey Therapeutics Inc. | ODTX | Healthcare | 0.03% | 2,893 | +2,893 | +100.00% | $54,128 |
Showing 9 of 9 holdings in the latest reporting period.